A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients
RD Bloom, J Trofe‐Clark, A Wiland… - Clinical …, 2013 - Wiley Online Library
An exploratory, post hoc analysis was performed using data from a prospective, multicenter,
open‐label, randomized, two‐period (14 d per period), two‐sequence, crossover, steady …
open‐label, randomized, two‐period (14 d per period), two‐sequence, crossover, steady …
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients
RD Bloom, J Trofe‐Clark, A Wiland, RR Alloway - Clinical Transplantation, 2013 - infona.pl
An exploratory, post hoc analysis was performed using data from a prospective, multicenter,
open‐label, randomized, two‐period (14 d per period), two‐sequence, crossover, steady …
open‐label, randomized, two‐period (14 d per period), two‐sequence, crossover, steady …
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients
RD Bloom, J Trofe-Clark, A Wiland, RR Alloway - 2013 - pubmed.ncbi.nlm.nih.gov
An exploratory, post hoc analysis was performed using data from a prospective, multicenter,
open-label, randomized, two-period (14 d per period), two-sequence, crossover, steady …
open-label, randomized, two-period (14 d per period), two-sequence, crossover, steady …
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients.
RD Bloom, J Trofe‐Clark, A Wiland… - Clinical …, 2013 - search.ebscohost.com
An exploratory, post hoc analysis was performed using data from a prospective, multicenter,
open-label, randomized, two-period (14 d per period), two-sequence, crossover, steady …
open-label, randomized, two-period (14 d per period), two-sequence, crossover, steady …
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients.
RD Bloom, J Trofe-Clark, A Wiland… - Clinical …, 2013 - europepmc.org
An exploratory, post hoc analysis was performed using data from a prospective, multicenter,
open-label, randomized, two-period (14 d per period), two-sequence, crossover, steady …
open-label, randomized, two-period (14 d per period), two-sequence, crossover, steady …